Press and news

 The Wall Street Journal recently published an article titled “IVF Testing Spurs a Debate Over Mosaic Embryos”, discussing the differing opinions regarding mosaicism amongst IVF specialists. 

At the 73rd AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE Scientific Congress (ASRM) IGENOMIX presents a new non-invasive method to predict endometrial receptivity using endometrial liquid biopsy The study was led by Prof. Carlos Simon and first author Dr. Felipe Vilella. Here the authors consider the use of endometrial fluid instead of traditional invasive biopsies, for a […]

Published in the PNAS Journal A scientific study led by Dr. Carlos Simon has for the first time drawn a connection between a decidualization defect of the maternal uterus and the onset of preeclampsia Until now, research efforts to understand why preeclampsia occurs had been focused on studying the placenta. Our study shows that a […]

The 4th Biomarker Meeting: Personalized Reproductive Medicine; Biomarkers for the Assessment of Ovarian Reserve, Gametes, Embryos, Endometrium and Pregnancy will take place on April 12th and 13th, 2018 in Valencia, Spain.

We are proud to announce our wide participation at this year ESHRE annual meeting in Geneva, Switzerland from July 2nd – July 5th, 2017.

20 June, 2017 This year’s Human Reproduction keynote lecture, which will open ESHRE’s Annual Meeting in Geneva, will be given by our CSO Prof. Carlos Simón, who will address one of the biggest audiences ever in reproductive medicine.

IGENOMIX at ESHRE 2017From 2 – 5 July at Palexpo venue, Geneva, Switzerland.

We are proud to announce that our product autologous adult bone marrow-derived non-expanded CD133+ haematopoietic stem cells (IGX1) was granted the Orphan Drug Designation (ODD) on March 15th 2017 by the European Medicines Agency (EMA). The product is aimed at the treatment of patients with the Asherman’s syndrome (AS), a rare disease defined by the presence of […]